VLA2001, the COVID-19 vaccine from Valneva, was today granted regulatory approval for use in the UK, seven months after the government terminated its contract with the French firm for 100 million doses, citing a “breach of obligations.”
The Medicines and Healthcare products Regulatory Agency (MHRA) awarded VLA2001 a conditional marketing authorization, becoming the first regulator worldwide to...







